Analysis Rocket Lab Rebounds as ARK Buys the Dip and Cantor Fitzgerald Holds Its Ground
Rocket Lab shares steadied at the start of the new trading week, climbing 3.0% to EUR 46.60 — with a second reading putting the advance at 3.2% to EUR 46.70...
Top Stories
Latest financial market updates and expert analysis
AI & Quantum Computing
View All
Defense & Aerospace
View All
Cryptocurrency
View All
Banking & Finance
View All
Latest News
Automotive & E-Mobility
Audi’s Shop-Floor Representatives Draw a Line: 700 Union Stewards Back Jobs, Pay and a Say in the Electric Shift
Roughly 700 IG Metall shop-floor representatives at Audi have closed ranks behind a single demand: no more savings packages at...
Analysis
AST SpaceMobile’s Credibility Test: Legal Clouds, Launch Timelines, and the Gap Between Progress and Proof
AST SpaceMobile has spent the past several weeks stacking up operational wins. A completed network integration test with TELUS. Three...
Analysis
Moderna’s Friday Slide Says More About Positioning Than About Science
Moderna’s 8.0% drop on Friday should be read as a warning against inflated expectations, not as evidence of an operational...
Analysis
Albemarle’s Lithium Story Meets a Tech-Sector Mood Swing
Albemarle shares closed Friday at 84.96 euros, down 3.0 percent, as a wave of risk aversion across US equity markets...
Analysis
Ocugen’s 2027 BLA Target Confirmed as Shareholders Face a Long Wait and a Dilution Vote
Ocugen has reaffirmed the regulatory timeline for its lead gene therapy, OCU400, even as the company’s shares continue to languish...
Analysis
Caterpillar Expands Compact Lineup as Analysts Flag Order Momentum and Margin Risks
Caterpillar rolled out five new compact machines on Friday, a product push that broadens its catalogue but leaves the central...
AI & Quantum Computing
Vertiv’s 4.3% Pullback Tracks a Sector-Wide AI Spending Reckoning, Not a Company Warning
Vertiv shares gave up 4.3% yesterday, caught in a technology-wide downdraft that also dragged down fellow data-center suppliers Comfort Systems...
Asian Markets
TSMC Ties Any Terafab Role to Operator Control as Arizona Nears 2027 Output
TSMC has made plain what it wants from any tie-up with Elon Musk’s Terafab venture: the keys to the factory...
Analysis
BioNTech’s BNT113 Misses Progression-Free Survival Goal, but AHEAD-MERIT Trial Soldiers On
BioNTech shares closed Friday at EUR 78.05, down 3.0% on the session, capping a bruising stretch for the Mainz-based vaccine...
Analysis
Ocugen’s 250-Million-Share Request Puts the 2027 Data Gap in Sharp Relief
Ocugen shareholders are being asked to look a long way down the road. The company’s pivotal Phase 3 trial of...